
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17369860
[patent_doc_number] => 20220024912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => COMPOUNDS FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/370201
[patent_app_country] => US
[patent_app_date] => 2021-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 166
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17370201
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/370201 | Compounds for treatment of cancer | Jul 7, 2021 | Issued |
Array
(
[id] => 19274410
[patent_doc_number] => 12024521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-02
[patent_title] => Isoquinoline derivatives, methods of synthesis and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/363712
[patent_app_country] => US
[patent_app_date] => 2021-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 20110
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17363712
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/363712 | Isoquinoline derivatives, methods of synthesis and uses thereof | Jun 29, 2021 | Issued |
Array
(
[id] => 18020496
[patent_doc_number] => 20220371995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => SYNTHESIS METHOD FOR HALOFUGINONE AND HALOFUGINONE INTERMEDIATES
[patent_app_type] => utility
[patent_app_number] => 17/359661
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17359661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/359661 | SYNTHESIS METHOD FOR HALOFUGINONE AND HALOFUGINONE INTERMEDIATES | Jun 27, 2021 | Abandoned |
Array
(
[id] => 17335939
[patent_doc_number] => 20220002270
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/356748
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16121
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356748
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356748 | Tetrazole derivatives as TRPA1 inhibitors | Jun 23, 2021 | Issued |
Array
(
[id] => 17314434
[patent_doc_number] => 20210403482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => TETRAZOLE DERIVATIVES AS TRPA1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/356782
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15515
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17356782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/356782 | Tetrazole derivatives as TRPA1 inhibitors | Jun 23, 2021 | Issued |
Array
(
[id] => 17140074
[patent_doc_number] => 20210308085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => BUTHIONINE SULFOXIMINE AND A METALLODRUG FOR THE TREATMENT OF CANCER, HIV OR A RHEUMATIC DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/351350
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8985
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17351350
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/351350 | Buthionine sulfoximine and a metallodrug for the treatment of cancer, HIV or a rheumatic disease | Jun 17, 2021 | Issued |
Array
(
[id] => 18369052
[patent_doc_number] => 11649206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-16
[patent_title] => Method for producing pyrrole compound
[patent_app_type] => utility
[patent_app_number] => 17/350013
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 15059
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350013 | Method for producing pyrrole compound | Jun 16, 2021 | Issued |
Array
(
[id] => 18646980
[patent_doc_number] => 20230292747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Composition for use in agriculture
[patent_app_type] => utility
[patent_app_number] => 18/008909
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008909
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008909 | Composition for use in agriculture | Jun 15, 2021 | Pending |
Array
(
[id] => 18646980
[patent_doc_number] => 20230292747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => Composition for use in agriculture
[patent_app_type] => utility
[patent_app_number] => 18/008909
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18008909
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/008909 | Composition for use in agriculture | Jun 15, 2021 | Pending |
Array
(
[id] => 17292139
[patent_doc_number] => 20210387978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-16
[patent_title] => CYCLOBUTYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/344947
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17344947
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/344947 | CYCLOBUTYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS | Jun 10, 2021 | Abandoned |
Array
(
[id] => 17595276
[patent_doc_number] => 20220144849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/345570
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39909
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345570
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345570 | Compounds that participate in cooperative binding and uses thereof | Jun 10, 2021 | Issued |
Array
(
[id] => 19809468
[patent_doc_number] => 12240839
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Cyclobutyl dihydroquinoline sulfonamide compounds
[patent_app_type] => utility
[patent_app_number] => 17/633151
[patent_app_country] => US
[patent_app_date] => 2021-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38785
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633151
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633151 | Cyclobutyl dihydroquinoline sulfonamide compounds | Jun 9, 2021 | Issued |
Array
(
[id] => 18517600
[patent_doc_number] => 11707470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-25
[patent_title] => Inositol derivatives for use in pathological crystallization
[patent_app_type] => utility
[patent_app_number] => 17/340163
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 14
[patent_no_of_words] => 14395
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340163 | Inositol derivatives for use in pathological crystallization | Jun 6, 2021 | Issued |
Array
(
[id] => 18107989
[patent_doc_number] => 20230000869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => NOVEL ALK2 INHIBITORS AND METHODS FOR INHIBITING BMP SIGNALING
[patent_app_type] => utility
[patent_app_number] => 17/340589
[patent_app_country] => US
[patent_app_date] => 2021-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17340589
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/340589 | ALK2 inhibitors and methods for inhibiting BMP signaling | Jun 6, 2021 | Issued |
Array
(
[id] => 17905457
[patent_doc_number] => 11459300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-04
[patent_title] => Deuterated compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/324318
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 35733
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324318 | Deuterated compounds and uses thereof | May 18, 2021 | Issued |
Array
(
[id] => 17274393
[patent_doc_number] => 20210380591
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => ANTHELMINTIC HETEROCYCLIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/324288
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 810
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324288 | Anthelmintic heterocyclic compounds | May 18, 2021 | Issued |
Array
(
[id] => 18685100
[patent_doc_number] => 11780817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Methods for preparing Favipiravir
[patent_app_type] => utility
[patent_app_number] => 17/323910
[patent_app_country] => US
[patent_app_date] => 2021-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17364
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/323910 | Methods for preparing Favipiravir | May 17, 2021 | Issued |
Array
(
[id] => 18202341
[patent_doc_number] => 11584723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Hydantoin containing deoxyuridine triphosphatase inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/320650
[patent_app_country] => US
[patent_app_date] => 2021-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49992
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320650
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/320650 | Hydantoin containing deoxyuridine triphosphatase inhibitors | May 13, 2021 | Issued |
Array
(
[id] => 18109523
[patent_doc_number] => 20230002403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/317423
[patent_app_country] => US
[patent_app_date] => 2021-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 151923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 368
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317423
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/317423 | Methods and compounds for restoring mutant p53 function | May 10, 2021 | Issued |
Array
(
[id] => 17243400
[patent_doc_number] => 20210363143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => PYRIDO-IMIDAZO RIFAMYCINS
[patent_app_type] => utility
[patent_app_number] => 17/314413
[patent_app_country] => US
[patent_app_date] => 2021-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17314413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/314413 | PYRIDO-IMIDAZO RIFAMYCINS | May 6, 2021 | Abandoned |